Binding and sequestration of poison frog alkaloids by a plasma globulin
eLife · 19.12.2023 · 12
DOI: 10.7554/elife.85096 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 19.12.2023. Verfasst von Aurora Alvarez-Buylla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Stanford University, Stanford, United States. Hauptthemen laut MEDLINE: Serpins, Globulins, Alkaloids. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Howard Hughes Medical Institute, National Science Foundation, New York Stem Cell Foundation.
Abstract (Originalsprache)
Alkaloids are important bioactive molecules throughout the natural world, and in many animals they serve as a source of chemical defense against predation. Dendrobatid poison frogs bioaccumulate alkaloids from their diet to make themselves toxic or unpalatable to predators. Despite the proposed roles of plasma proteins as mediators of alkaloid trafficking and bioavailability, the responsible proteins have not been identified. We use chemical approaches to show that a ~50 kDa plasma protein is the principal alkaloid-binding molecule in blood of poison frogs. Proteomic and biochemical studies establish this plasma protein to be a liver-derived alkaloid-binding globulin (ABG) that is a member of the serine-protease inhibitor (serpin) family. In addition to alkaloid-binding activity, ABG sequesters and regulates the bioavailability of ‘free’ plasma alkaloids in vitro. Unexpectedly, ABG is not related to saxiphilin, albumin, or other known vitamin carriers, but instead exhibits sequence and structural homology to mammalian hormone carriers and amphibian biliverdin-binding proteins. ABG represents a new small molecule binding functionality in serpin proteins, a novel mechanism of plasma alkaloid transport in poison frogs, and more broadly points toward serpins acting as tunable scaffolds for small molecule binding and transport across different organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Stanford University, Stanford, United States.
- Sarafan ChEM-H, Stanford University, Stanford, United States.
- Wu Tsai Institute for Neuroscience, Stanford University, Stanford, United States.
- Department of Pathology, Stanford University, Stanford, United States.
- Wu Tsai Human Performance Alliance, Stanford University, Stanford, United States.
- Department of Radiology, Stanford University, Stanford, United States.
ORCID-Profile: Aurora Alvarez-Buylla, Jonathan Z Long, Lauren A O'Connell
Förderung
- Howard Hughes Medical Institute
- National Science Foundation
- New York Stem Cell Foundation
- National Science Foundation Graduate Research Fellowship Program
- Fundacion Alfonso Martin Escudero
- Wu Tsai Human Performance Alliance
Zitieren
APA
Alvarez-Buylla, A., Fischer, M. T., Moya Garzon, M. D., Rangel, A. E., Tapia, E. E., Tanzo, J. T., Soh, H. T., Coloma, L. A., Long, J. Z., & O'Connell, L. A. (2023). Binding and sequestration of poison frog alkaloids by a plasma globulin. eLife, 12. https://doi.org/10.7554/elife.85096
Vancouver
Alvarez-Buylla A, Fischer MT, Moya Garzon MD, Rangel AE, Tapia EE, Tanzo JT, et al. Binding and sequestration of poison frog alkaloids by a plasma globulin. eLife. 2023;12. doi:10.7554/elife.85096
BibTeX
@article{AlvarezBuylla2023,
author = {Alvarez-Buylla, Aurora and Fischer, Marie-Therese and Moya Garzon, Maria Dolores and Rangel, Alexandra E and Tapia, Elicio E and Tanzo, Julia T and Soh, H Tom and Coloma, Luis A and Long, Jonathan Z and O'Connell, Lauren A},
title = {Binding and sequestration of poison frog alkaloids by a plasma globulin},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.85096}
}
EUVIMED